What are Jazz Pharmaceuticals' main areas of focus?

Jazz Pharmaceuticals primarily focuses on developing treatments for narcolepsy, oncology, pain, and psychiatry.

Which key products does Jazz Pharmaceuticals offer?

Key products from Jazz Pharmaceuticals include Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.

When and where was Jazz Pharmaceuticals founded?

Jazz Pharmaceuticals was founded in March 2003 and is headquartered in Dublin, Ireland.

Home / Business and Economy / Jazz Pharma: Innovating Treatments for Sleep, Cancer & Pain

Jazz Pharma: Innovating Treatments for Sleep, Cancer & Pain

19 Nov

•

Summary

Jazz Pharmaceuticals focuses on narcolepsy, oncology, pain, and psychiatry.
Key products include Xyrem, Xywav, and Zepzelca.
The company was founded in March 2003 and is based in Dublin, Ireland.

Jazz Pharma: Innovating Treatments for Sleep, Cancer & Pain

Jazz Pharmaceuticals Plc is a dynamic biopharmaceutical entity committed to the discovery, development, and commercialization of vital pharmaceutical products. The company's core focus areas include narcolepsy, oncology, pain management, and psychiatric disorders, addressing unmet medical needs.

Its extensive product pipeline boasts well-known treatments such as Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. These medications underscore Jazz Pharmaceuticals' dedication to improving patient outcomes in complex disease areas.

Established in March 2003, Jazz Pharmaceuticals operates with its headquarters situated in Dublin, Ireland. The company continues to advance its mission of developing innovative therapies for patients worldwide.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.